| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |